Please Wait
Applying Filters...
menu
    • menu
    Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

    Stock Recap
    #PipelineProspector

    Menu

    Insulin Lispro

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    28/03/2025 Eli Lilly
    U.S.A
    		 Lilly del Caribe, Inc. 229MF10064 Insulin Lispro (genetical recombination) 2017-03-13 2017-12-25 65th Infantry Road, Km. 12.6, Carolina, Puerto Rico 00985
    28/03/2025 Eli Lilly
    U.S.A
    		 Eli Lilly and Company 226MF10225 Insulin Lispro (genetical recombination) 2014-12-08 2017-12-25 Lilly Corporate Center, Indianapolis, Indiana 46285, USA